Genetic Testing

India-Based Dhiti Omics is Now Live on SOPHiA DDM™India-Based Dhiti Omics is Now Live on SOPHiA DDM™

India-Based Dhiti Omics is Now Live on SOPHiA DDM™

The diagnostics company has implemented the SOPHiA DDM™ Platform to enhance its solid tumor testing BOSTON and ROLLE, Switzerland, July 4, 2024…

12 months ago
Myriad Genetics Earns 2024 Great Place To Work® Certification™Myriad Genetics Earns 2024 Great Place To Work® Certification™

Myriad Genetics Earns 2024 Great Place To Work® Certification™

SALT LAKE CITY, July 02, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and…

12 months ago
Thermal Cyclers Market Worth 1.86 Billion 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd.Thermal Cyclers Market Worth 1.86 Billion 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd.

Thermal Cyclers Market Worth 1.86 Billion 2031- Exclusive Report by InsightAce Analytic Pvt. Ltd.

JERSEY CITY, N.J., June 24, 2024 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report…

1 year ago
Avalon Healthcare Solutions Welcomes Federal Measures to Combat Lab FraudAvalon Healthcare Solutions Welcomes Federal Measures to Combat Lab Fraud

Avalon Healthcare Solutions Welcomes Federal Measures to Combat Lab Fraud

Fraud and abuse in lab testing linked to looser telehealth regulations. TAMPA, Fla., June 20, 2024 /PRNewswire/ -- Avalon Healthcare…

1 year ago
C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug DevelopmentC-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development

C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development

TUCSON, Ariz. and CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, June 20, 2024 (GLOBE NEWSWIRE) -- Critical Path Institute (C-Path),…

1 year ago
Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) TestingApplied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing

Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing

Partnership Will Aid Physicians in Precision Prescribing Decisions Based on Applied DNA's TR8™ Pharmacogenomic (PGx) Test STONY BROOK, NY /…

1 year ago
Genetic Technologies Expands Operational Capacity in North AmericaGenetic Technologies Expands Operational Capacity in North America

Genetic Technologies Expands Operational Capacity in North America

Global leader in personalized predictive genetics launches testing operations for geneType disease risk assessments at US based, world-leading genetic laboratory,…

1 year ago
Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of HealthApplied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health

Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health

STONY BROOK, NY / ACCESSWIRE / June 13, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"),…

1 year ago